达卢生坦
中文名称 | 达卢生坦 |
---|---|
中文同义词 | 达卢生坦;(S)-2-((4,6-二甲氧基嘧啶-2-基)氧基)-3-甲氧基-3,3-二苯丙酸;达尔斯坦坦 |
英文名称 | Darusentan |
英文同义词 | Darusentan;(S)-2-((4,6-dimethoxypyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic acid;S-Darusentan;HMR 4005;HMR4005;HMR-4005;LU 135252; LU-135252; LU135252; HMR-4005; HMR 4005; HMR4005; DARUSENTAN;(2S)-2-(4,6-DIMETHOXYPYRIMIDIN-2-YL)OXY-3-METHOXY-3,3-DI(PHENYL)PROPANOIC ACID |
CAS号 | 171714-84-4 |
分子式 | C22H22N2O6 |
分子量 | 410.42 |
EINECS号 | |
相关类别 | |
Mol文件 | 171714-84-4.mol |
结构式 |
达卢生坦 性质
沸点 | 587.3±60.0 °C(Predicted) |
---|---|
密度 | 1.268±0.06 g/cm3(Predicted) |
储存条件 | 2-8°C |
溶解度 | DMF:10mg/mL; DMSO:2mg/mL;乙醇:2mg/mL; PBS (pH 7.2):不溶 |
形态 | 固体 |
酸度系数(pKa) | 1.82±0.10(Predicted) |
颜色 | 白色至米白色 |
Darusentan ((S)-Darusentan) competes for radiolabeled endothelin binding in rat aortic vascular smooth muscle cells (RAVSMs) membranes with single-site kinetics, exhibiting a K i =13 nM. In isolated endothelium-denuded rat aortic rings, Darusentan inhibits endothelin-induced vascular contractility with a pA 2 =8.1±0.14. Darusentan ( 0.001-1μM) inhibits ET-1-induced signaling in cultured RAVSMs.
Darusentan (30 mg/kg per day orally for weeks 3 and 4) reverses aortic alterations produced by infusion of Norepinephrine (2.5 μg/kg per min subcutaneously for 2 and 4 weeks) in male Sprague Dawley rats.
Animal Model: | Twenty-four (eight per group) male Sprague Dawley rats weighing 175±200 g |
Dosage: | 30 mg/kg |
Administration: | Administered orally in rat food for weeks 3 and 4 |
Result: | Reversed aortic alterations produced by infusion of Norepinephrine (2.5 μg/kg). |
安全信息
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024/08/19 | HY-15404 | Darusentan | 1 mg | 495元 | |
2024/08/19 | HY-15404 | 达卢生坦 Darusentan | 171714-84-4 | 5mg | 1300元 |